What is the price-to-earnings ratio of argenx?
The price-earnings ratio of argenx is currently -365.
argenx P/E 2024
argenx P/E
-365
Ticker
ARGX.BR
ISIN
NL0010832176
WKN
A11602
As of Oct 6, 2024, argenx's P/E ratio was -365, a 415.1% change from the -70.86 P/E ratio recorded in the previous year.
The argenx P/E history
argenx Aktienanalyse
What does argenx do?
Argenx SE is a biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of serious diseases. The company was founded in 2008 and is headquartered in Gent, Belgium. Argenx utilizes an innovative technology platform, the Simple Antibody platform, to develop customized antibodies with high efficacy. Argenx operates in two main business areas: clinical development and licensing. The company aims to produce outstanding therapeutic agents from each of its platform technologies and drug candidates, which can be used as antibody therapies against serious autoimmune diseases or cancer. Argenx's main product is the drug Efgartigimod, a monoclonal antibody developed for the treatment of multiple autoimmune diseases, particularly generalized Myasthenia Gravis (GMG). The drug is currently in clinical development. In recent years, Argenx has made significant progress in the development of new drugs. For example, the company has announced the discovery of new antibodies for the treatment of Myasthenia Gravis, rheumatoid arthritis, and various types of cancer. Licensing these development pipelines opens up new opportunities for Argenx to create additional therapy options for patients with serious illnesses. Argenx has also established partnerships with leading pharmaceutical companies such as Shire and AbbVie to expand its technology platform and drug candidates into new areas of application. The company is currently working on the development of therapies for rare and serious diseases that have no satisfactory treatment options. With the advancement of its innovative technology platform and the expansion of its portfolio of drug candidates, Argenx is on a promising path to play a leading role in the industry. The company is building an extensive network of partnerships and collaborations to accelerate the further development of its technology platform and products, and to achieve further success in the search for new therapeutic applications and areas of application. Looking ahead, Argenx is poised to play a significant role in the biopharmaceutical industry, particularly in the development of personalized therapy options for the treatment of serious diseases where no satisfactory treatment options currently exist. Argenx is proud of its dedicated team of employees who strive every day to realize the company's vision - to help patients cope with serious illnesses through new and innovative therapies. Output: Argenx SE is a biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of serious diseases. argenx ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering argenx's P/E Ratio
The Price to Earnings (P/E) Ratio of argenx is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing argenx's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of argenx is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in argenx’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about argenx stock
How has the price-earnings ratio of argenx changed compared to last year?
The price-to-earnings ratio of argenx has increased by 415.1% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of argenx high compared to other companies?
Yes, the price-to-earnings ratio of argenx is high compared to other companies.
How does an increase in the price-earnings ratio of argenx affect the company?
An increase in the price-earnings ratio of argenx would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of argenx affect the company?
A decrease in the price-earnings ratio of argenx would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of argenx?
Some factors that influence the price-earnings ratio of argenx are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does argenx pay?
Over the past 12 months, argenx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, argenx is expected to pay a dividend of 0 USD.
What is the dividend yield of argenx?
The current dividend yield of argenx is .
When does argenx pay dividends?
argenx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of argenx?
argenx paid dividends every year for the past 0 years.
What is the dividend of argenx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is argenx located?
argenx is assigned to the 'Health' sector.
Wann musste ich die Aktien von argenx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of argenx from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.
When did argenx pay the last dividend?
The last dividend was paid out on 10/6/2024.
What was the dividend of argenx in the year 2023?
In the year 2023, argenx distributed 0 USD as dividends.
In which currency does argenx pay out the dividend?
The dividends of argenx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The argenx stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von argenx
Our stock analysis for argenx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of argenx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
